cancer-related cognitive impairment chemobrain
Conditions
Interventions
Mijnfittebrein.nl (MFB) will be the intervention used in the study. MFB has
originally been developed by Radboud University Nijmegen under the name Brain
Aging Monitor, to improve cognitive function
Sponsors
Vrije Universiteit Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: * Having received chemotherapy treatment for any recently diagnosed non-CNS cancer * Chemotherapy treatment has been completed * Presence of cognitive complaints * >
Exclusion criteria
Exclusion criteria: * Primary or secondary brain tumours * Insufficient mastery of the Dutch language * History of brain injury with loss of consciousness * History of brain surgery * Currently under active treatment for psychiatric disorders * Neurodegenerative disorders * Self-reported substance abuse * Severe visual impairments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility study: Compliance rate of the participants after 3 months, if there is a compliance of more than 50% after 3 months and the feedback from the structured interview is mostly positive we will continue with the main study. Main study: The change in subjective cognitive functioning between baseline and 6 months later, comparing the effect of MFB to no intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Feasibility study: Usability Areas of improvement Main study: The change in objective cognitive functioning between baseline and 6 months. The change in lifestyle functions between baseline and 6 months. The influence of other parameters such as level of education, work performance, self-efficacy, type of cancer, type of treatment, age, gender, psychological functioning on the effect of the intervention. | — |
Countries
Netherlands
Outcome results
None listed